Abstract
The pharmaceutical industry must direct additional focus on the development of agents to prevent or minimize symptoms of cancer and its treatment, and maximize the quality of life of cancer patients. This paper covers the current status of cancer chemotherapy, opportunties for intervention, supportive care measures, and challenges to the pharmuceutical industry in oncologic drug development.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Markman, M. Cancer Drug Development Problems and Opportunities. Ther Innov Regul Sci 32, 1–5 (1998). https://doi.org/10.1177/009286159803200101
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286159803200101